Structure-Based Drug Design, June 4-5, Cambridge, MA

Article View: bionet.software

Article #2461

#2461

From: James Prudhomme
Date: Thu, 17 May 2012 18:57

68 lines
5165 bytes

*** Please distribute this message to your colleagues. Thank you. ***

Register Today!

CHI and Bio-IT World Present the Twelfth Annual
Structure-Based Drug Design: Predicting Biological and Kinetic Profiles from
Structure

June 6-8, 2012
Royal Sonesta Hotel Boston, Cambridge, MA
 <http://www.healthtech.com/sbd> http://www.healthtech.com/sbd

About the event:

Structure-based drug design took nearly two decades of multiple, parallel
technological improvements to arrive at its 
current mainstream position in medicinal chemistry. Developments in computer
graphics, high-power radiation sources, 
computational processing power, refinement protocols, virtual screening and
crystallography were all necessary to 
create the environment for rapid, iterative structure-based drug discovery.
Given the crisis facing the pharmaceutical 
industry in the translation of early stage drug discovery results, a
different set of tools, concerned with algorithms 
and methods for developing best in class drugs that engage biological
targets with kinetically optimized potency 
and selectivity will need to be refined. In this conference, we bring to
focus recent advancements in this field from 
an experienced faculty.

 

Keynote Address:

Binding Kinetics in Drug Discovery

David Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug
Discovery (iRND3)

Themed Sessions:
- Structure to Function
- Free Energy Calculation and Molecular Dynamics Simulation
- GPCR
- Fragment-Based Design
- Druggability and Kinetics-Based Drug Design
- Trends and Advances

Download a PDF brochure at
<http://www.healthtech.com/Conferences_Overview.aspx?ekfrm=111573&libID=1115
28>
http://www.healthtech.com/Conferences_Overview.aspx?ekfrm=111573&libID=11152
8


Register at  <https://chidb.com/register/2012/sbd/reg.asp>
https://chidb.com/register/2012/sbd/reg.asp or call 781-972-5400.

To inquire about sponsoring and/or exhibiting, contact Jon Stroup at
781-972-5483,  <mailto:jstroup@healthtech.com> jstroup@healthtech.com


Please contact me with any questions.  

James Prudhomme
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
 <mailto:jprudhomme@healthtech.com> jprudhomme@healthtech.com

Technical Details

Message-ID: <mailman.295.1337281106.3456.bio-soft@net.bio.net>

Path:

arc1-ca.pugleaf.net!pr3ni10013pbb.0!nntp.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail

Show Full Headers

Complete Article Headers

X-Google-Thread: fa6b6,a2ad773a21d13fda,start
X-Google-NewGroupId: yes
X-Google-Attributes: gid6710630482,domainid0,public,usenet
X-Google-Language: ENGLISH,ASCII-7-bit
Received: by 10.68.220.230 with SMTP id pz6mr3500612pbc.3.1337281132896;
        Thu, 17 May 2012 11:58:52 -0700 (PDT)
Path: arc1-ca.pugleaf.net!pr3ni10013pbb.0!nntp.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail
NNTP-Posting-Date: Thu, 17 May 2012 13:58:51 -0500
X-Envelope-From: jprudhomme@healthtech.com
From: "James Prudhomme" <jprudhomme@healthtech.com>
To: <Bio-soft@magpie.bio.indiana.edu>
Date: Thu, 17 May 2012 14:57:35 -0400
MIME-Version: 1.0
X-Mailer: Microsoft Office Outlook 12.0
Thread-Index: AcznLoF/2XEPdZUXQlWcNaPlCjD9YgVWtfjABn4QhYAAAA048ALwIWnwAb5I6FACyMHYsAAAD+1QAAAHwEA=
x-cr-hashedpuzzle: AudQ B9m6 CdKe EdSs EdXv FBnZ FPC8 Fu0l G5jG IM1Q INXL Icaa
 KHi9 KHwg KMy4 L6XJ; 1;
 YgBpAG8ALQBzAG8AZgB0AEAAbgBlAHQALgBiAGkAbwAuAG4AZQB0AA==;
 Sosha1_v1; 7; {5CDDF6F5-BC63-4C5E-8B51-D4FA0F87F185};
 agBwAHIAdQBkAGgAbwBtAG0AZQBAAGgAZQBhAGwAdABoAHQAZQBjAGgALgBjAG8AbQA=;
 Thu, 17 May 2012 18:57:33 GMT;
 UwB0AHIAdQBjAHQAdQByAGUALQBCAGEAcwBlAGQAIABEAHIAdQBnACAARABlAHMAaQBnAG4ALAAgAEoAdQBuAGUAIAA0AC0ANQAsACAAQwBhAG0AYgByAGkAZABnAGUALAAgAE0AQQA=
x-cr-puzzleid: {5CDDF6F5-BC63-4C5E-8B51-D4FA0F87F185}
X-Originating-IP: [66.228.71.161]
X-AntiSpam: Checked for restricted content by Gordano's AntiSpam Software
X-Mailman-Approved-At: Thu, 17 May 2012 13:58:24 -0500
X-Content-Filtered-By: Mailman/MimeDel 2.1.4
X-BeenThere: bio-soft@net.bio.net
X-Mailman-Version: 2.1.4
Precedence: list
Organization: BIOSCI/IUBio, Biology Dept., Indiana University
subject: Structure-Based Drug Design, June 4-5, Cambridge, MA
Newsgroups: bionet.software
Message-ID: <mailman.295.1337281106.3456.bio-soft@net.bio.net>
Approved: BIOSCI Approval Key <biosci-approval-key@net.bio.net>
X-Auth: PGPMoose V1.1 PGP bionet.software
 iQCVAwUBT7VKUqCIqsWvyF5FAQHNugQAsL1pWgnqCutEX5VjwkrsH4uPVCcgh2fb
 Ci/0EMg8mySST4hnSNAOoGL/43tpfXrnnWxvkG40JcGi6lfeRtYtZ9jR4rBQ4+/v
 wxhpXWTuDOIeEU9kF8Wa81R7MiRs7ck1seD3Yc1HASMZvMk0T3u3alZuSLNl7LhZ
 3YPP9a7n8v8= =19ID
Lines: 69
X-Usenet-Provider: http://www.giganews.com
X-Trace: sv3-Iv6bJ4f2WpU//q4oLZMvbIwkuhcjRrw7b+9vWR/Yh2ed0h3iyJhP75hyx/B5kzOH7iZyBBszd9SEcxQ!6lXNh8heGq2t4EbsUxmGrXojnM2MwSBK7sSI3dPxaW97Kv2FgPpbXldobBUpxL+vHJwOn6LxvpV4!yJIP
X-Complaints-To: abuse@giganews.com
X-DMCA-Notifications: http://www.giganews.com/info/dmca.html
X-Abuse-and-DMCA-Info: Please be sure to forward a copy of ALL headers
X-Abuse-and-DMCA-Info: Otherwise we will be unable to process your complaint properly
X-Postfilter: 1.3.40
X-Original-Bytes: 4735
Content-Language: en-us
Content-Type: text/plain;
 charset="us-ascii"
Content-Transfer-Encoding: 7bit